In today’s retail landscape filled with intense competition and discouraging news about store closures and challenging sales figures, Global Market Development Center (GMDC)|Retail Tomorrow is focused on designing new strategies for retailers and suppliers to navigate a path forward to evolve and th
new competitors, generic drug price deflation, Medicare Part D plans pushing patients toward in-network or mail order pharmacies — and all of this before direct and indirect remuneration (DIR) fees. For
As drug stores remake themselves under the banner of health and wellness, they are taking a second look at anything that may strike consumers as off-brand.
It’s no secret that the retail industry is experiencing unprecedented disruption and a decline in foot traffic as a result of the proliferation of e-commerce and the subsequent migration of products from physical stores to online marketplaces.
and to use that knowledge to go beyond traditional manufacturing and deliver services and experiences (and, yes, products) that are entirely “right” for each moment in their lives.
The self-care movement is playing a key role in reshaping health care in a way that drug store retailers and manufacturers cannot afford to ignore.
The legacy business model in consumer and retail is the pipe through which value is generated upstream and delivered to consumers downstream. As everyone is aware, a powerful alternative has emerged. Today “platform” enterprises such as Alibaba, Amazon, Tencent and Uber are dominant business titans.
It is seldom that a trend benefits all key players in a given market, but the proliferation of self-care and the growth of the over-the-counter medication market is one of those trends. Drug retailers, consumers and the U.S.
Today’s product landscape is highly competitive. Speed-to-market continues to be an important product launch factor, but it isn’t everything. Often, overly eager companies introduce a new CPG item too quickly while overlooking critical steps that could prevent costly mistakes.
and is forecast to reach $63.5 billion by 2024, a
a bold departure for a pharmacy chain in this country, one that sadly has yet to be matched by any of the company’s peers — was intended to discourage smokers from indulging in a habit that is clearly
The news out of Rhode Island that Judy Sansone, chief merchant at CVS Pharmacy, will shortly retire signals more than the end of a remarkable and productive retail career.
In a recent column, Chain Drug Review editor David Pinto described the 2019 NACDS Annual Meeting this way: “In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the [NACDS] Annual Meeting, held each spring, remains the standard by which retail meetings are
the use of marijuana in plant form or its basic extracts. Although some states have legalized its use, the Food and Drug Administration has not approved marijuana in plant
The last three years have been very tough for retail pharmacies.
As specialty drugs grow in importance and prominence, this is an ideal moment to consider the essential and evolving roles retail pharmacies play in this significant health care category.
